These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 34780978)

  • 21. Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial.
    Stoll F; Blank A; Mikus G; Czock D; Foerster KI; Hermann S; Häußler K; Muhareb A; Hummler S; Weiss J; Burhenne J; Haefeli WE
    Trials; 2020 Jun; 21(1):584. PubMed ID: 32600363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.
    Lee Z; Rayner CR; Forrest JI; Nachega JB; Senchaudhuri E; Mills EJ
    Am J Trop Med Hyg; 2021 Jan; 104(1):35-38. PubMed ID: 33236703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
    Quiros Roldan E; Biasiotto G; Magro P; Zanella I
    Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.
    Barratt-Due A; Olsen IC; Nezvalova-Henriksen K; Kåsine T; Lund-Johansen F; Hoel H; Holten AR; Tveita A; Mathiessen A; Haugli M; Eiken R; Kildal AB; Berg Å; Johannessen A; Heggelund L; Dahl TB; Skåra KH; Mielnik P; Le LAK; Thoresen L; Ernst G; Hoff DAL; Skudal H; Kittang BR; Olsen RB; Tholin B; Ystrøm CM; Skei NV; Tran T; Dudman S; Andersen JT; Hannula R; Dalgard O; Finbråten AK; Tonby K; Blomberg B; Aballi S; Fladeby C; Steffensen A; Müller F; Dyrhol-Riise AM; Trøseid M; Aukrust P;
    Ann Intern Med; 2021 Sep; 174(9):1261-1269. PubMed ID: 34251903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Meo SA; Klonoff DC; Akram J
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4539-4547. PubMed ID: 32373993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. It is time to drop hydroxychloroquine from our COVID-19 armamentarium.
    Kashour T; Tleyjeh IM
    Med Hypotheses; 2020 Nov; 144():110198. PubMed ID: 33254507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19.
    García-Albéniz X; Del Amo J; Polo R; Morales-Asencio JM; Hernán MA
    Eur J Epidemiol; 2022 Aug; 37(8):789-796. PubMed ID: 35943669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.
    Sun J; Chen Y; Fan X; Wang X; Han Q; Liu Z
    Postgrad Med; 2020 Sep; 132(7):604-613. PubMed ID: 32496926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications.
    Kumar R; Sharma A; Srivastava JK; Siddiqui MH; Uddin MS; Aleya L
    Environ Sci Pollut Res Int; 2021 Aug; 28(30):40431-40444. PubMed ID: 33447984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of trial registry entries for randomized clinical trials investigating COVID-19 medical prevention and treatment.
    Karlsen APH; Wiberg S; Laigaard J; Pedersen C; Rokamp KZ; Mathiesen O
    PLoS One; 2020; 15(8):e0237903. PubMed ID: 32817689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The future is now: our experience starting a remote clinical trial during the beginning of the COVID-19 pandemic.
    Liu HH; Ezekowitz MD; Columbo M; Khan O; Martin J; Spahr J; Yaron D; Cushinotto L; Kapelusznik L
    Trials; 2021 Sep; 22(1):603. PubMed ID: 34493311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.
    Ferreira A; Oliveira-E-Silva A; Bettencourt P
    J Med Virol; 2021 Feb; 93(2):755-759. PubMed ID: 32644224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
    Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R
    Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans.
    Gerlovin H; Posner DC; Ho YL; Rentsch CT; Tate JP; King JT; Kurgansky KE; Danciu I; Costa L; Linares FA; Goethert ID; Jacobson DA; Freiberg MS; Begoli E; Muralidhar S; Ramoni RB; Tourassi G; Gaziano JM; Justice AC; Gagnon DR; Cho K
    Am J Epidemiol; 2021 Nov; 190(11):2405-2419. PubMed ID: 34165150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings.
    Abena PM; Decloedt EH; Bottieau E; Suleman F; Adejumo P; Sam-Agudu NA; Muyembe TamFum JJ; Seydi M; Eholie SP; Mills EJ; Kallay O; Zumla A; Nachega JB
    Am J Trop Med Hyg; 2020 Jun; 102(6):1184-1188. PubMed ID: 32323646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis.
    Risch HA
    Am J Epidemiol; 2020 Nov; 189(11):1218-1226. PubMed ID: 32458969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.
    Chen Y; Li MX; Lu GD; Shen HM; Zhou J
    Int J Biol Sci; 2021; 17(6):1538-1546. PubMed ID: 33907517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of clinical and methodological characteristics of early COVID-19 treatment clinical trials: so much work, so many lost opportunities.
    Mainoli B; Machado T; Duarte GS; Prada L; Gonçalves N; Ferreira JJ; Costa J
    BMC Med Res Methodol; 2021 Feb; 21(1):42. PubMed ID: 33637044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.